1. Home
  2. WST vs LII Comparison

WST vs LII Comparison

Compare WST & LII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo West Pharmaceutical Services Inc.

WST

West Pharmaceutical Services Inc.

HOLD

Current Price

$303.47

Market Cap

18.5B

Sector

Health Care

ML Signal

HOLD

Logo Lennox International Inc.

LII

Lennox International Inc.

HOLD

Current Price

$488.69

Market Cap

15.8B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
WST
LII
Founded
1923
1895
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
18.5B
15.8B
IPO Year
2004
1999

Fundamental Metrics

Financial Performance
Metric
WST
LII
Price
$303.47
$488.69
Analyst Decision
Buy
Hold
Analyst Count
7
13
Target Price
$320.86
$566.58
AVG Volume (30 Days)
829.5K
455.0K
Earning Date
04-23-2026
04-29-2026
Dividend Yield
0.28%
1.05%
EPS Growth
1.49
1.11
EPS
1.92
22.79
Revenue
$2,886,900,000.00
$5,195,300,000.00
Revenue This Year
$6.76
$6.85
Revenue Next Year
$6.22
$5.76
P/E Ratio
$45.57
$21.69
Revenue Growth
1.95
N/A
52 Week Low
$203.74
$434.06
52 Week High
$322.34
$689.44

Technical Indicators

Market Signals
Indicator
WST
LII
Relative Strength Index (RSI) 75.56 50.42
Support Level $234.43 $479.34
Resistance Level $322.34 $498.78
Average True Range (ATR) 7.67 17.05
MACD 4.11 2.36
Stochastic Oscillator 75.29 56.16

Price Performance

Historical Comparison
WST
LII

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About LII Lennox International Inc.

Lennox International manufacturers and distributes heating, ventilating, air conditioning, and refrigeration products for the North American replacement (75% of sales) and new construction (25% of sales) markets. Residential HVAC (home comfort solutions) accounted for 67% of sales and commercial HVAC (building climate solutions) accounted for the remaining 33% of sales. To be clear, Lennox's commercial exposure is what its peers refer to as "residential and light commercial," lacks the scale and complexity of what is referred to as an "applied" solution. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand.

Share on Social Networks: